Uninterrupted Continuous and Intermittent Nebulizer Therapy in a COVID-19 Patient Using Sequential Vibratory Mesh Nebulizers: A Case Report

Interruptions in continuous nebulized pulmonary vasodilators, such as epoprostenol, can potentially result in clinical deterioration in respiratory status. Coadministration of other intermittent nebulized therapies may require opening the ventilator circuit to facilitate administration. However, in...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of aerosol medicine 2020-12, Vol.33 (6), p.357-360
Hauptverfasser:	Elnadoury, Ola, Beattie, Jason, Lubinsky, Anthony S
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Inhalation Anti-Bacterial Agents - administration & dosage Antibiotics Bronchodilator Agents - administration & dosage Bronchodilators Case reports Clinical deterioration COVID-19 COVID-19 - diagnosis COVID-19 - drug therapy COVID-19 - physiopathology COVID-19 - therapy Cross Infection - diagnosis Cross Infection - drug therapy Cross Infection - microbiology Drug Administration Schedule Drug Resistance, Multiple, Bacterial Equipment Design Fatal Outcome Health care Humans Male Medical personnel Middle Aged Nebulizers and Vaporizers Occupational exposure Patients Pneumonia, Bacterial - diagnosis Pneumonia, Bacterial - drug therapy Pneumonia, Bacterial - microbiology Prostacyclin Respiration, Artificial Severe acute respiratory syndrome coronavirus 2 Treatment Outcome Vasodilators Ventilators
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!